Convened and run by QUT, The Bridge Program is also supported by the government body MTPConnect, with industry matched funding to deliver this exciting education program that provides the necessary training to enable successful commercialisation of Australian pharmaceutical research.

Along with MTPConnect and QUT, The Bridge Program involves support and input from a consortium of 9 pharmaceutical companies, universities and industry associations and is the outcome of a growing sector wanting to propel its status on the national and international market as a leader in the innovation economy.

This project is supported by MTPConnect, both through its Industry Growth Centre Project Fund Program and the Medical Research Future Fund’s Biomedical Translation Bridge program. Learn more at

2020 Partnership Opportunity

In 2020 the Bridge Program will receive funding through MTPConnect’s Biomedical Translation Bridge Fund along with industry matched funding from partner companies. The Bridge Consortium therefore has an opportunity to include new members to support and take part in the design and delivery of this unique program. Please contact us using the form below to express your interest in this opportunity.